Adherence to Surveillance Guidelines in Nondysplastic Barrett's Esophagus

被引:5
作者
Dalal, Kunal S. [1 ]
Coffing, Jessica [2 ]
Imperiale, Thomas F. [1 ]
机构
[1] Indiana Univ Sch Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA
[2] Richard L Roudebush VA Med Ctr, Ctr Innovat Hlth Serv Res & Dev, Indianapolis, IN USA
关键词
Barrett's esophagus; nondysplastic Barrett's; Barrett's surveillance; MEDICAL POSITION STATEMENT; PRACTICE PATTERNS; ENDOSCOPIC SURVEILLANCE; PREMALIGNANT CONDITIONS; UPDATED GUIDELINES; MANAGEMENT; DIAGNOSIS; GASTROENTEROLOGISTS; ADENOCARCINOMA; REGISTRY;
D O I
10.1097/MCG.0000000000000777
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Surveillance patterns in Barrett's esophagus (BE) are not well characterized. Guidelines published between 2002 and 2008 recommended surveillance esophagogastroduodenoscopy (sEGD) at 3-year intervals for nondysplastic BE (NDBE). We assessed guideline adherence in incident NDBE in a Veterans Affairs (VA)-based study. Methods: At a single VA center, we identified incident cases of biopsy-confirmed NDBE between January, 2006 and December, 2008. We excluded patients aged 76 years and above and those who developed BE-associated dysplasia or cancer during follow-up. All sEGDs through October, 2014 were documented. Our primary criteria classified cases as guideline adherent if a sEGD was performed within 6 months of each expected 3-year surveillance interval; in cases with 2 sEGDs, 1 sEGD >6 months, and 1 year outside an interval was allowed if the average interval was between 2.5 and 3.5 years. Comorbidity, primary care encounters, presence of long-segment BE (LSBE), endoscopist recommendations, and Charlson comorbidity index (CCI) were assessed. Results: We identified 110 patients (96.4% male, 93.6% white) with mean age 58.98.5 years at index EGD. Median follow-up was 6.7 years (range, 3.7 to 8.6). Thirty-three (30.0%) cases were guideline adherent; 77 (70.0%) cases were nonadherent, including 52 (47.3%) with irregular surveillance and 25 (22.7%) with no surveillance. Forty cases (14 adherent) had 1 sEGD, 36 (18 adherent) had 2, 8 (1 adherent) had 3, and 1 nonadherent case had 4. Adherent cases were significantly older (61.5 vs. 57.9 y, P = 0.04), and tended to have more LSBE (33.3% vs. 20.8%, P = 0.16). There were no differences between adherent and nonadherent cases in annual primary care encounters (72.7% vs. 66.2%, P = 0.66), CCI >= 4 (15.2% vs. 15.6%, P = 0.95), biopsy-positive sEGDs (75.8% vs. 76.6%, P = 0.92), and any recommendation for subsequent surveillance (81.8% vs. 77.9%, P = 0.65). A logistic regression model using age, CCI, and LSBE showed an independent association between adherence and older age (P = 0.03). Conclusions: In a single-center VA cohort, sEGD of NDBE was mostly nonadherent to guidelines. Adherent cases were older at baseline with a trend toward more LSBE. A larger study is needed to identify medical and social factors associated with adherence or nonadherence to surveillance.
引用
收藏
页码:217 / 222
页数:6
相关论文
共 22 条
  • [1] Adherence to Biopsy Guidelines for Barrett's Esophagus Surveillance in the Community Setting in the United States
    Abrams, Julian A.
    Kapel, Robert C.
    Lindberg, Guy M.
    Saboorian, Mohammad H.
    Genta, Robert M.
    Neugut, Alfred I.
    Lightdale, Charles J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (07) : 736 - 742
  • [2] Surveillance in Barrett's Esophagus: An Audit of Practice
    Ajumobi, Adewale
    Bahjri, Khaled
    Jackson, Christian
    Griffin, Ronald
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (06) : 1615 - 1621
  • [3] Current practice compared with the international guidelines: endoscopic surveillance of Barrett's esophagus
    Amamra, Nassira
    Touzet, Sandrine
    Colin, Cyrille
    Ponchon, Thierry
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2007, 13 (05) : 789 - 794
  • [4] Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study
    Crockett, Seth D.
    Lipkus, Isaac M.
    Bright, Stephanie D.
    Sampliner, Richard E.
    Wang, Kenneth K.
    Boolchand, Vikram
    Lutzke, Lori S.
    Shaheen, Nicholas J.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2012, 75 (01) : 23 - U59
  • [5] Curvers W L, 2007, Ned Tijdschr Geneeskd, V151, P1879
  • [6] Management of Barrett's esophagus in the UK: Overtreated and underbiopsied but improved by the introduction of a national randomized trial
    Das, Debasish
    Ishaq, Savid
    Harrison, Rebecca
    Kosuri, Kiran
    Harper, Edward
    Decaestecker, John
    Sampliner, Richard
    Attwood, Stephen
    Barr, Hugh
    Watson, Peter
    Moayyedi, Paul
    Jankowski, Janusz
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (05) : 1079 - 1089
  • [7] The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis
    Desai, Tusar K.
    Krishnan, Kumar
    Samala, Niharika
    Singh, Jashanpreet
    Cluley, John
    Perla, Subaiah
    Howden, Colin W.
    [J]. GUT, 2012, 61 (07) : 970 - 976
  • [8] Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212
  • [9] ESGE Survey: worldwide practice patterns amongst gastroenterologists regarding the endoscopic management of Barrett's esophagus
    Dunn, Simon J.
    Neilson, Laura J.
    Hassan, Cesare
    Sharma, Prateek
    Guy, Claire
    Rees, Colin J.
    [J]. ENDOSCOPY INTERNATIONAL OPEN, 2016, 4 (01) : E36 - E41
  • [10] Practice patterns of surveillance endoscopy in a Veterans Affairs database of 29,504 patients with Barrett's esophagus
    El-Serag, Hashem B.
    Duan, Zhigang
    Hinojosa-Lindsey, Marilyn
    Hou, Jason
    Shakhatreh, Mohammad
    Naik, Aanand D.
    Chen, G. John
    Street, Richard L., Jr.
    Kramer, Jennifer R.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2012, 76 (04) : 743 - 755